External quality assessment for detection of Chlamydia trachomatis

Journal of Clinical Microbiology

Volumn 43, Issue 3, 2005, Pages 1341-1347

  Chalker, V J ^a   Vaughan, H ^a   Patel, P ^a   Rossouw, A ^a   Seyedzadeh, H ^a   Gerrard, K ^a   James, V L A ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MOLECULAR SYSTEMATICS; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; TECHNIQUE; UTERINE CERVIX;

CHLAMYDIA TRACHOMATIS; HUMANS; IMMUNOENZYME TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RETROSPECTIVE STUDIES;

CHLAMYDIA TRACHOMATIS;

EID: 14944347057     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.3.1341-1347.2005     Document Type: Article

References (28)

1. Abravaya, K., J. Huff, R. Marshall, B. Merchant, C. Mullen, G. Schneider, and J. Robinson. 2003. Molecular beacons as diagnostic tools: technology and applications. Clin. Chem. Lab. Med. 41:468-474.
2. Barnes, R. C., A. M. Rompalo, and W. E. Stamm. 1987. Comparison of Chlamydia trachomatis serovars causing rectal and cervical infections. J. Infect. Dis. 156:953-958.
3. Batteiger, B. E., J. Fraiz, W. J. Newhall, B. P. Katz, and R. B. Jones. 1989. Association of recurrent chlamydial infection with gonorrhea. J. Infect. Dis. 159:661-669.
4. Berg, E. S., G. Anestad, H. Moi, G. Storvold, and K. Skaug. 1997. False-negative results of a ligase chain reaction assay to detect Chlamydia trachomatis due to inhibitors in urine. Eur. J. Clin. Microbiol. Infect. Dis. 16:727-731.
5. Boisvert, J. F., L. A. Koutsky, R. J. Suchland, and W. E. Stamm. 1999. Clinical features of Chlamydia trachomatis rectal infection by serovar among homosexually active men. Sex. Transm. Dis. 26:392-398.
6. Boyadzhyan, B., T. Yashina, J. H. Yatabe, M. Patnaik, and C. S. Hill. 2004. Comparison of the APTIMA CT and GC assays with the APTIMA combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol. 42:3089-3093.
7. Castriciano, S., K. Luinstra, D. Jang, J. Patel, J. Mahony, J. Kapala, and M. Chernesky. 2002. Accuracy of results obtained by performing a second ligase chain reaction assay and PCR analysis on urine samples with positive or near-cutoff results in the LCx test for Chlamydia trachomatis. J. Clin. Microbiol. 40:2632-2634.
8. Chan, E. L., K. Brandt, K. Olienus, N. Antonishyn, and G. B. Horsman. 2000. Performance characteristics of the Becton Dickinson ProbeTec System for direct detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male and female urine specimens in comparison with the Roche Cobas System. Arch. Pathol. Lab. Med. 124:1649-1652.
9. Chernesky, M., D. Jang, S. Chong, J. Sellors, and J. Mahony. 2003. Impact of urine collection order on the ability of assays to identify Chlamydia trachomatis infections in men. Sex. Transm. Dis. 30:345-347.
10. Chernesky, M. A., D. Jang, J. Sellors, K. Luinstra, S. Chong, S. Castriciano, and J. B. Mahony. 1997. Urinary inhibitors of polymerase chain reaction and ligase chain reaction and testing of multiple specimens may contribute to lower assay sensitivities for diagnosing Chlamydia trachomatis infected women. Mol. Cell. Probes 11:243-249.
11. Chong, S., D. Jang, X. Song, J. Mahony, A. Petrich, P. Barriga, and M. Chernesky. 2003. Specimen processing and concentration of Chlamydia trachomatis added can influence false-negative rates in the LCx assay but not in the APTIMA Combo 2 assay when testing for inhibitors. J. Clin. Microbiol. 41:778-782.
12. Dean, D., R. J. Suchland, and W. E. Stamm. 2000. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J. Infect. Dis. 182:909-916.
13. Gaydos, C. A., M. Theodore, N. Dalesio, B. J. Wood, and T. C. Quinn. 2004. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens. J. Clin. Microbiol. 42:3041-3045.
14. Goessens, W. H., J. W. Mouton, W. I. van der Meijden, S. Deelen, T. H. van Rijsoort-Vos, N. Lemmens-den Toom, H. A. Verbrugh, and R. P. Verkooyen. 1997. Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine. J. Clin. Microbiol. 35:2628-2633.
15. Gronowski, A. M., S. Copper, D. Baorto, and P. R. Murray. 2000. Reproducibility problems with the Abbott Laboratories LCx assay for Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol. 38:2416-2418.
16. Jensen, I. P., P. Thorsen, and B. R. Moller. 1997. Sensitivity of ligase chain reaction assay of urine from pregnant women for Chlamydia trachomatis. Lancet 349:329-330.
17. Kellogg, J. A., J. W. Seiple, J. L. Klinedinst, and J. S. Levisky. 1991. Impact of endocervical specimen quality on apparent prevalence of Chlamydia trachomatis infections diagnosed using an enzyme-linked immunosorbent assay method. Arch. Pathol. Lab. Med. 115:1223-1227.
18. Land, S., S. Tabrizi, A. Gust, E. Johnson, S. Garland, and E. M. Dax. 2002. External quality assessment program for Chlamydia trachomatis diagnostic testing by nucleic acid amplification assays. J. Clin. Microbiol. 40:2893-2896.
19. Mahony, J., S. Chong, D. Jang, K. Luinstra, M. Faught, D. Dalby, J. Sellors, and M. Chernesky. 1998. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J. Clin. Microbiol. 36:3122-3126.
20. McCartney, R. A., J. Walker, and A. Scoular. 2001. Detection of Chlamydia trachomatis in genitourinary medicine clinic attendees: comparison of strand displacement amplification and ligase chain reaction. Br. J. Biomed. Sci. 58:235-238.
21. Millman, K., C. M. Black, R. E. Johnson, W. E. Stamm, R. B. Jones, E. W. Hook, D. H. Martin, G. Bolan, S. Tavare, and D. Dean. 2004. Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States. J. Bacteriol. 186:2457-2465.
22. Newhall, W. J., R. E. Johnson, S. DeLisle, D. Fine, A. Hadgu, B. Matsuda, D. Osmond, J. Campbell, and W. E. Stamm. 1999. Head-to-head evaluation of five Chlamydia tests relative to a quality-assured culture standard. J. Clin. Microbiol. 37:681-685.
23. Notomi, T., Y. Ikeda, A. Okadome, and A. Nagayama. 1998. The inhibitory effect of phosphate on the ligase chain reaction used for detecting Chlamydia trachomatis. J. Clin. Pathol. 51:306-308.
24. Schachter, J. 2001. NAATs to diagnose Chlamydia trachomatis genital infection: a promise still unfulfilled. Expert Rev. Mol. Diagn. 1:137-144.
25. Taylor-Robinson, D. 1996. Tests for infection with Chlamydia trachomatis. Int. J. STD AIDS 7:19-25.
26. Verkooyen, R. P., G. T. Noordhoek, P. E. Klapper, J. Reid, J. Schirm, G. M. Cleator, M. Leven, and G. Hoddevik. 2003. Reliability of nucleic acid amplification methods for detection of Chlamydia trachomatis in urine: results of the first international collaborative quality control study among 96 laboratories. J. Clin. Microbiol. 41:3013-3016.
27. Wang, S. P., and J. T. Grayston. 1991. Three new serovars of Chlamydia trachomatis: Da, Ia, and L2a. J. Infect. Dis. 163:403-405.
28. Watson, E. J., A. Templeton, I. Russell, J. Paavonen, P. A. Mardh, A. Stary, and B. S. Pederson. 2002. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J. Med. Microbiol. 51:1021-1031.